Optinose names Terry Kohler as CFO

Optinose (OPTN) announced the appointment of Terry Kohler as CFO. Kohler was most recently the CFO for Verrica Pharmaceuticals (VRCA), a dermatology therapeutics company, where he supported commercial preparations for the launch of a topical treatment for molluscum contagiosum and research and development pipeline investments. Kohler is an experienced biotech finance leader with over 20 years of business experience.